Oneject Indonesia
Raising the Bar in Healthcare Safety through Innovation

Oneject Indonesia (Oneject) is redefining medical safety with its expertise in manufacturing lifesaving innovations like Auto-Disable Syringe (ADS), Smart Syringe, and a broad range of medical devices under Infusion Therapy, Blood Purification, Blood Collection, Diagnostics, and Radiology.

As a leading manufacturer of safety-engineered syringes in Indonesia, Oneject holds majority market share in ADS and Smart Syringes, which provide advanced alternatives to conventional syringes. These devices, designed to prevent reuse and safeguard against infections, have played a crucial role in reducing the prevalence of standard syringes nationwide. Founded to support the country’s National Healthcare Immunization Program, Oneject has consistently demonstrated its commitment to enhancing public health through advanced technology and global quality standards that are certified by the World Health Organization (WHO). Its dedication to safety and innovation has set new benchmarks within national and international healthcare landscapes.

Today, Oneject’s impact extends beyond Indonesia’s borders. With groundbreaking products, the company is setting standards for injection safety globally. By redefining best practices, the company is leading the charge in shaping the future of injection safety, making a profound impact on global health.

Creating Impact at Every Step

Oneject’s innovation journey began with the ADS, a product that bolstered injection safety by permanently locking the syringe after a single use. Initially developed in collaboration with global healthcare organizations, this device is now central to mass immunization efforts, where accidental or intentional syringe reuse poses persistent threats.

The ADS limits these dangers by ensuring that it is rendered unusable after one injection, significantly reducing infection risks and supporting safer healthcare environments on a massive scale.

Building on the success of ADS, Oneject introduced the Smart Syringe, which integrates the auto-disable function with an added safety needle feature to protect healthcare providers. This syringe addresses the issue of needlestick injuries, a severe risk to healthcare workers. The Smart Syringe’s safety mechanism locks and covers the needle, preventing accidental exposure.

These innovations exemplify Oneject’s broader commitment to safeguarding everyone in healthcare, from patients to providers, as global immunization efforts expand.

Oneject’s dedication to improving healthcare safety does not stop at syringes. Traditionally, medical sterilization depended on ethylene oxide (EO) gas and gamma radiation, methods that may carry health risks and environmental concerns.

To address these issues, Oneject embraced E-Beam technology, a cleaner, faster, and safer sterilization method that eliminates the toxic residues associated with traditional methods.

“Unlike traditional methods, E-Beam sterilization uses a high-voltage beam to quickly and efficiently sterilize products, getting the job done in a fraction of the time,” says Edwin Yahya, Senior Vice President of Oneject. This method eliminates the hazardous residues associated with gamma and EO sterilization, reducing environmental impact and potential health risks for users.

Today, Oneject is among a few companies in Indonesia that have implemented E-Beam technology, raising the bar for safety and sustainability in medical sterilization.

OneGoal Driving Excellence, Safety and Expansion

Its “OneGoal” mission drives Oneject—a guiding principle that unites the internal team and external stakeholders in a shared vision to Reinvent Healthcare through innovative research and development, enhancing existing products, as well as evolving services.

Unlike traditional methods, E-Beam sterilization uses a high-voltage beam to quickly and efficiently sterilize products, getting the job done in a fraction of the time

For customers, OneGoal represents the drive to expand healthcare accessibility, improve product safety and elevate the overall quality of healthcare. Internally, it is a call to action for every team member to pursue excellence and continuous improvement. By leveraging the expertise of its talented team, strong brand, and culture of constant improvement, Oneject is positioned to transform Healthcare Programs and drive lasting change in the medical consumables industry.

Building a culture of quality takes years, and for over two decades, Oneject has committed to its high-quality standard, delivering compliant products. This dedication has made it one of the leading suppliers to Indonesia’s Ministry of Health, consistently proving its reliability. With a trusted market record, Oneject supplies syringes to major global NGOs and meets stringent international standards as a WHO-certified supplier.

The impact has transformed Indonesia’s immunization efforts and positioned Oneject as a leader in public health. Through a partnership with PT Itama Ranoraya Tbk. (IRRA. JK), a publicly listed Indonesian distribution company, Oneject replaced conventional syringes with ADS in the nation’s immunization programs. The result has been significantly reduced disease transmission through syringe reuse, improving healthcare outcomes for millions.

Oneject exemplifies purposeful innovation every step of the way. By setting high standards for healthcare safety and quality, and expanding into new product areas such as Blood Purification and Blood Collection, it has been developing into a leading high quality medical devices manufacturer in Indonesia. Today, Oneject is expanding its customer base domestically and globally, growing its product portfolio, and is keen to be a high-quality solution provider and supplier for the healthcare industry around the world.